About Hunter Imaging Group
Clinical Trials at Hunter Imaging Group
During the past decade, Hunter Imaging Group conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Hunter Imaging Group
According to Clinical.Site data, the most researched conditions in "Hunter Imaging Group" are
"Chronic Pain" (1 trials), "Osteoarthritis, Hip" (1 trials), "Osteoarthritis, Knee" (1 trials) and "Spondylitis, Ankylosing" (1 trials). Many other conditions were trialed in "Hunter Imaging Group" in a lesser frequency.
Clinical Trials Intervention Types at Hunter Imaging Group
Most popular intervention types in "Hunter Imaging Group" are "Biological" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Etanercept" (1 trials), "NSAID" (1 trials), "Tanezumab 2.5 mg" (1 trials) and "Tanezumab 5 mg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hunter Imaging Group
The vast majority of trials in "Hunter Imaging Group" are
2 trials for "All" genders.
Clinical Trials Status at Hunter Imaging Group
Currently, there are NaN active trials in "Hunter Imaging Group".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Hunter Imaging Group,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Hunter Imaging Group, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".